Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00893269 · ClinicalTrials.gov registry record · Phase 1
The Effect of Marijuana and Prescription Medications in Mood, Performance and Sleep
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT00893269: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT00893269 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00893269, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
Heavy marijuana users report experiencing trouble sleeping when they try to quit, but this has not been carefully studied. This research is being done to learn more about sleep function in heavy marijuana users, and to determine whether a medication approved for treating insomnia can help restore normal sleep function during brief periods of abstinence.
Interventions
- DRUG Placebo
- DRUG eszopiclone
- DRUG zolpidem
- DRUG ramelteon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00893269
The ClinicalTrials.gov registry entry for NCT00893269 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00893269 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00893269 about?
NCT00893269 is a clinical study titled "The Effect of Marijuana and Prescription Medications in Mood, Performance and Sleep". Heavy marijuana users report experiencing trouble sleeping when they try to quit, but this has not been carefully studied. This research is being done to learn more about sleep function in heavy marijuana users, and to determine whether a medication approved for treating insomnia can help restore no...
What is the current status of trial NCT00893269?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2008-10. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00893269?
The interventions under investigation include: Placebo (DRUG), eszopiclone (DRUG), zolpidem (DRUG), ramelteon (DRUG).
Who is sponsoring clinical trial NCT00893269?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.